← Eichor
Study identifier: NCT05411614 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Hybrid Ablation of Atrial Fibrillation in Heart Failure

Condition: Persistent Atrial Fibrillation · Atrial Fibrillation, Persistent · Atrial Arrhythmia  ·  Sponsor: St. George's Hospital, London

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A randomised controlled trial to assess the efficacy of staged hybrid ablation when compared with standard catheter ablation in patients with non-paroxysmal atrial fibrillation (AF) and Heart Failure

This description comes directly from the study's public registry record.

Talk to the study team

Riyaz A Kaba  ·  020 8725 4571  ·  rkaba@sgul.ac.uk

Omar Ahmed  ·  020 8725 4571  ·  m2109536@sgul.ac.uk

Always discuss trial participation with your own doctor first.

Locations (7)

Ashford & St Peters Hospital NHS TrustChertsey, United KingdomRecruiting
Epsom General HospitalEpsom, United KingdomRecruiting
Cromwell HospitalLondon, United KingdomActive Not Recruiting
Royal Surrey County HospitalLondon, United KingdomRecruiting
St Anthonys HospitalLondon, United KingdomActive Not Recruiting
St Georges at Kingston HospitalLondon, United KingdomRecruiting
St Georges University of LondonLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05411614